The global prefilled hemostasis agents market is on the verge of substantial expansion, with forecasts estimating a remarkable growth from USD 5.5 billion in 2023 to USD 12.2 billion by 2033. This growth trajectory indicates a compound annual growth rate (CAGR) of 8.3% throughout the forecast period, driven by a confluence of factors transforming the …